会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 101. 发明申请
    • METHOD AND DEVICE FOR DIALYSIS
    • 用于透析的方法和装置
    • US20090209918A1
    • 2009-08-20
    • US12206674
    • 2008-09-08
    • Rick Berglund
    • Rick Berglund
    • A61M5/32A61M25/00
    • A61M1/3655A61F2/06A61F2/064A61M39/0247A61M2039/0258A61M2039/0273
    • A method and system are provided for performing dialysis. The system provides needleless vascular access which reduces the repeated traumas of conventional dialysis by providing a vascular graft and port combination which interfaces with a specially-designed catheter system. The installed implant is low profile, small and stable, and saddles the vessel to secure the protruding surface tissue above. The stability of the port is maintained by features that encompass the vessel and the surrounding tissue. These features are enhanced by the catheter attachment, which also provides reduced trauma and provides convenient access to the implant for performance of dialysis functions.
    • 提供了一种执行透析的方法和系统。 该系统提供无针管血管通路,通过提供与专门设计的导管系统相连接的血管移植物和端口组合,减少常规透析的重复创伤。 所安装的植入物具有薄型,小型和稳定的特征,并且将该容器鞍形以固定上方的突出表面组织。 端口的稳定性由包含容器和周围组织的特征保持。 通过导管附件增强了这些特征,这也提供了减少的创伤,并提供了便于进入植入物以进行透析功能。
    • 106. 发明申请
    • EXTRACORPOREAL CELL-BASED THERAPEUTIC DEVICE AND DELIVERY SYSTEM
    • 基于细胞的细胞治疗设备和递送系统
    • US20070269489A1
    • 2007-11-22
    • US11670123
    • 2007-02-01
    • H. Humes
    • H. Humes
    • A61F6/06A61K39/00A61P43/00C12M1/00
    • A61M5/14A61M1/3655A61M1/3687A61M1/3689A61M2202/09
    • Extracorporeal cell-based therapeutic devices and delivery systems are disclosed which provide a method for therapeutic delivery of biologically active molecules produced by living cells in response to a dynamic physiologic environment. Exemplary designs are disclosed. In a first exemplary embodiment the device includes long hollow fibers in which a layer of cells are grown within the intraluminal volume or within a double hollow-filled chamber. In another exemplary embodiment the device includes a wafer or a series of wafers forms a substrate onto which cells are grown. The wafer(s) are then inserted into a device. The devices are intended to be extracorporeal. Disclosed is a device for delivering a pre-selected molecule, for example, a hormone, into a mammal's systemic circulation. The device may also deliver a member of different cell products. The device comprises an anchoring element that can be anchored to an inner wall of an extracorporeal tube for blood. The device also comprises a capsule that is held in place within the extracorporeal tube for blood or fluid by an anchor. The device is adapted to secure viable cells which produce and secrete the pre-selected molecule into blood or fluid passing the capsule. The invention also provides a minimally invasive method for percutaneously introducing into a preselected blood vessel or body cavity the device of the invention.
    • 公开了基于体外细胞的治疗装置和递送系统,其提供了响应于动态生理环境而由活细胞产生的生物活性分子的治疗递送的方法。 公开了示例性设计。 在第一示例性实施例中,该装置包括长的中空纤维,其中细胞层在管腔内体积内生长或在双重中空填充的腔室内生长。 在另一个示例性实施例中,该装置包括晶片或一系列晶片形成其上生长细胞的基底。 然后将晶片插入设备中。 这些设备旨在体外。 公开了用于将预先选择的分子例如激素递送到哺乳动物的全身循环中的装置。 该装置还可以递送不同细胞产品的成员。 该装置包括锚定元件,该锚定元件可以锚定到用于血液的体外管的内壁。 该装置还包括一个胶囊,其通过锚固件保持在用于血液或流体的体外管内的适当位置。 该装置适于将产生和分泌预先选择的分子的活细胞固定到通过胶囊的血液或液体中。 本发明还提供了一种用于经皮引入本发明的装置的预选血管或体腔的微创方法。